EyeGate Pharma Reaches 50% Randomization of Patients in Pivotal Study

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/14/2026

1. USO
2. SPY
3. QTTB
4. BIIB
5. AAPL
6. ERAS
7. PSKY
8. JPM
9. SPCX
10. NFLX

Go back to EyeGate Pharma Reaches 50% Randomization of Patients in Pivotal Study
(NASDAQ: EYEG) Delayed: 34.76 -0.12 (0.34%)
Previous Close $34.88    52 Week High $5.09 
Open $34.76    52 Week Low $1.11 
Day High $34.76    P/E N/A 
Day Low $34.76    EPS $0.00 
Volume 19